Uncle Sam Wants You … to Help Stop Insurers’ Bogus Medicare Advantage Sales Tactics
(By Susan Jaffe for KFF Health News) After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare
Read More
CMS
Bipartisan anger over Medicare Advantage denials on the rise
(By Rylee Wilson for Becker’s Hospital Review) Concerns about Medicare Advantage denials are on the rise in Washington, Politico reported
Read MoreManufacturers need to be more open about a dangerous Alzheimer’s drug side effect
(By Madhav Thambisetty for STAT) Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover
Read MoreMedicare Advantage plans are not for everyone
There are many advantages to selecting a Medicare Advantage plan over traditional Medicare. Medicare Advantage plans have a limit on
Read MoreCMS: Medicare Advantage received $16.6B in improper payments in 2023
(By Rylee Wilson for Becker’s Hospital Review) CMS paid Medicare Advantage organizations an estimated $16.6 billion in overpayments in fiscal
Read MoreMedicare Advantage ads still under CMS scrutiny
(By Rylee Wilson for Becker’s Hospital Review) From October to December, airwaves are flooded with advertisements for Medicare Advantage plans,
Read MoreCompensation Is Key to Fixing Primary Care Shortage
(By Michelle Andrews for KFF Health News) Money talks. The United States faces a serious shortage of primary care physicians
Read MoreUnitedHealth faces class action lawsuit over algorithmic care denials in Medicare Advantage plans
(By Casey Ross and Bob Herman for STAT) A class action lawsuit was filed Tuesday against UnitedHealth Group and a
Read MoreBiden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say
(By Arthur Allen for KFF Health News) The Biden administration’s first major step toward imposing limits on the pharmacy benefit
Read MoreIt pays to review your choices
We are almost a month into Medicare Open Enrollment for 2024; have you reviewed other plans yet? If you are
Read More